FIRST MANHATTAN CO. LLC. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 981 filers reported holding NOVARTIS A G in Q2 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.4%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$5,243,752
-0.5%
51,480
-1.4%
0.02%0.0%
Q2 2023$5,270,832
-71.2%
52,233
-73.7%
0.02%
-72.9%
Q1 2023$18,297,144
-0.2%
198,882
-1.6%
0.07%
+4.5%
Q4 2022$18,327,435
+19.9%
202,022
+0.5%
0.07%
+3.1%
Q3 2022$15,285,000
-11.0%
201,100
-1.0%
0.06%
-5.8%
Q2 2022$17,170,000
-3.5%
203,134
+0.2%
0.07%
+19.0%
Q1 2022$17,794,000
-31.6%
202,783
-31.8%
0.06%
-32.6%
Q4 2021$26,025,000
+6.3%
297,537
-0.6%
0.09%
-4.4%
Q3 2021$24,475,000
-10.5%
299,287
-0.2%
0.09%
-10.0%
Q2 2021$27,361,000
+6.7%
299,889
-0.1%
0.10%
-9.9%
Q1 2021$25,654,000
-9.5%
300,121
-0.0%
0.11%
-18.4%
Q4 2020$28,345,000
+331.4%
300,171
+297.2%
0.14%
+300.0%
Q3 2020$6,571,000
-0.5%
75,573
-0.1%
0.03%
-10.5%
Q2 2020$6,606,000
-2.0%
75,645
-7.5%
0.04%
-13.6%
Q1 2020$6,742,000
-11.6%
81,773
+1.5%
0.04%
+15.8%
Q4 2019$7,631,000
+5.6%
80,595
-3.1%
0.04%
-5.0%
Q3 2019$7,225,000
-4.4%
83,148
+0.5%
0.04%
-4.8%
Q2 2019$7,554,000
-2.0%
82,733
+3.2%
0.04%
-4.5%
Q1 2019$7,708,000
+30.4%
80,175
+16.4%
0.04%
+18.9%
Q4 2018$5,911,000
+1.7%
68,892
+2.1%
0.04%
+19.4%
Q3 2018$5,810,000
+11.4%
67,442
-2.3%
0.03%
+3.3%
Q2 2018$5,216,000
-9.5%
69,056
-3.1%
0.03%
-9.1%
Q1 2018$5,763,000
-3.7%
71,281
-0.0%
0.03%0.0%
Q4 2017$5,984,000
-2.2%
71,283
-0.0%
0.03%
-5.7%
Q3 2017$6,121,000
+2.4%
71,299
-0.4%
0.04%0.0%
Q2 2017$5,975,000
-8.9%
71,591
-19.0%
0.04%
-10.3%
Q1 2017$6,561,000
-75.8%
88,341
-76.2%
0.04%
-76.4%
Q4 2016$27,085,000
-11.3%
371,856
-3.9%
0.16%
-11.3%
Q3 2016$30,541,000
-17.5%
386,796
-13.8%
0.19%
-18.1%
Q2 2016$37,036,000
+6.3%
448,868
-6.7%
0.23%
+6.1%
Q1 2016$34,834,000
-22.5%
480,879
-8.0%
0.21%
-22.5%
Q4 2015$44,955,000
-9.3%
522,500
-3.1%
0.28%
-13.2%
Q3 2015$49,539,000
-7.4%
538,940
-0.9%
0.32%
+0.6%
Q2 2015$53,503,000
-0.9%
544,066
-0.6%
0.32%
+1.6%
Q1 2015$53,974,000
+4.8%
547,350
-1.5%
0.31%
+6.5%
Q4 2014$51,496,000
-3.4%
555,754
-1.9%
0.29%
-5.8%
Q3 2014$53,316,000
+2.8%
566,416
-1.2%
0.31%
-5.8%
Q2 2014$51,885,000
+3.0%
573,127
-3.3%
0.33%
-0.9%
Q1 2014$50,368,000
+2.8%
592,427
-2.9%
0.33%
+2.5%
Q4 2013$49,018,000
-1.5%
609,829
-6.0%
0.32%
-6.6%
Q3 2013$49,751,000
+6.9%
648,562
-0.6%
0.35%
+8.4%
Q2 2013$46,549,000652,6920.32%
Other shareholders
NOVARTIS A G shareholders Q2 2018
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders